Alex Nemiroff - 14 May 2026 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Reporting relationship: General Counsel and Secretary
Issuer ticker: PRAX
Reported as of: 14 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2026, 21:45:18 UTC
Prior SEC filing: 13 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Alex Nemiroff

Key filing fact

Alex Nemiroff filed Form 4 for Praxis Precision Medicines, Inc. (PRAX) on 19 May 2026.

Key facts

This page summarizes Alex Nemiroff's Form 4 filing for Praxis Precision Medicines, Inc. (PRAX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2026, 21:45.

Change

Previous filing in this sequence was filed on 13 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001827760 Primary reporting owner

Nemiroff Alex

Relationship: General Counsel and Secretary
Address: C/O PRAXIS PRECISION MEDICINES, INC., 99 HIGH STREET, 30TH FLOOR, BOSTON
Signature: /s/ Alex Nemiroff
Signature date: 19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRAX transaction

Common Stock

Award

Transaction value
Shares: +78
Change %: +0.3%
Price: $167.94^*
Shares after: 26,011
Date: 14 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).